يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Martin, Lainie P."', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.

    المؤلفون: Martin, Lainie P.1 lainie.martin@fccc.edu, Konner, Jason A.2 konnerj@MSKCC.org, Moore, Kathleen N.3 kathleen-moore@ouhsc.edu, Seward, Shelly M.4 sseward@med.wayne.edu, Matulonis, Ursula A.5 ursula_matulonis@dfci.harvard.edu, Perez, Raymond P.6 perezonc@gmail.com, Su, Ying7 ying.su@immmunogen.com, Berkenblit, Anna7 anna.berkenblit@immunogen.com, Ruiz-Soto, Rodrigo7 rodrigo.ruizsoto@gmail.com, Birrer, Michael J.8 mbirrer@mgh.harvard.edu

    المصدر: Gynecologic Oncology. Nov2017, Vol. 147 Issue 2, p402-407. 6p.

    مصطلحات موضوعية: *JUNO protein, *PROTEIN expression, *OVARIAN epithelial cancer, *GENE targeting, *CANCER relapse, *CANCER treatment


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.

    المؤلفون: Richardson, Debra L.1,2 (AUTHOR) debra-richardson@ouhsc.edu, Moore, Kathleen N.1,2 (AUTHOR) kathleen-moore@ouhsc.edu, Vergote, Ignace3 (AUTHOR) ignace.vergote@uzleuven.be, Gilbert, Lucy4 (AUTHOR) lucy.gilbert@mcgill.ca, Martin, Lainie P.5 (AUTHOR) lainie.martin@pennmedicine.upenn.edu, Mantia-Smaldone, Gina M.6 (AUTHOR) gina.mantia-smaldone@fccc.edu, Castro, Cesar M.7 (AUTHOR) cmcastro@mgh.harvard.edu, Provencher, Diane8 (AUTHOR) diane.provencher.med@ssss.gouv.qc.ca, Matulonis, Ursula A.9 (AUTHOR) ursula_matulonis@dfci.harvard.edu, Stec, James10 (AUTHOR) james.stec@immunogen.com, Wang, Yuemei10 (AUTHOR) yuemei.wang@immunogen.com, Method, Michael10 (AUTHOR) michael.method@immunogen.com, O'Malley, David M.1,11 (AUTHOR) david.o'malley@osumc.edu

    المصدر: Gynecologic Oncology. Jun2024, Vol. 185, p186-193. 8p.

    مصطلحات موضوعية: *ANTIBODY-drug conjugates, *OVARIAN cancer, *BEVACIZUMAB, *CARBOPLATIN, *FOLIC acid, *OVARIAN epithelial cancer

    الشركة/الكيان: UNITED States. Food & Drug Administration


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.

    المؤلفون: Shah, Payal D.1,2 (AUTHOR), Wethington, Stephanie L.3 (AUTHOR), Pagan, Cheyenne4 (AUTHOR), Latif, Nawar4 (AUTHOR), Tanyi, Janos4 (AUTHOR), Martin, Lainie P.2 (AUTHOR), Morgan, Mark4 (AUTHOR), Burger, Robert A.4 (AUTHOR), Haggerty, Ashley4 (AUTHOR), Zarrin, Haley4 (AUTHOR), Rodriguez, Diego4 (AUTHOR), Domchek, Susan1,2 (AUTHOR), Drapkin, Ronny1,4 (AUTHOR), Shih, Ie-Ming3 (AUTHOR), Smith, Simon A.5 (AUTHOR), Dean, Emma5 (AUTHOR), Gaillard, Stéphanie3 (AUTHOR), Armstrong, Deborah3 (AUTHOR), Torigian, Drew A.6 (AUTHOR), Hwang, Wei-Ting7 (AUTHOR)

    المصدر: Gynecologic Oncology. Nov2021, Vol. 163 Issue 2, p246-253. 8p.

    مصطلحات موضوعية: *OVARIAN epithelial cancer, *OLAPARIB, *POLY(ADP-ribose) polymerase, *ATAXIA telangiectasia, *DISEASE progression, *GYNECOLOGIC cancer


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.

    المؤلفون: O'Malley, David M.1 (AUTHOR) David.O'Malley@osumc.edu, Matulonis, Ursula A.2 (AUTHOR) Ursula_Matulonis@dfci.harvard.edu, Birrer, Michael J.3 (AUTHOR) mbirrer@uab.edu, Castro, Cesar M.4 (AUTHOR) Castro.Cesar@mgh.harvard.edu, Gilbert, Lucy5 (AUTHOR) lucy.gilbert@mcgill.ca, Vergote, Ignace6 (AUTHOR) ignace.vergote@uzleuven.be, Martin, Lainie P.7 (AUTHOR) Lainie.Martin@uphs.upenn.edu, Mantia-Smaldone, Gina M.8 (AUTHOR) Gina.Mantia-Smaldone@fccc.edu, Martin, Antonio González9 (AUTHOR) agonzalezma@unav.es, Bratos, Raquel10 (AUTHOR) rbratosl@hospiten.com, Penson, Richard T.4 (AUTHOR) Penson.Richard@mgh.harvard.edu, Malek, Karim11 (AUTHOR) karim.malek@immunogen.com, Moore, Kathleen N.12,13 (AUTHOR) Kathleen-Moore@ouhsc.edu

    المصدر: Gynecologic Oncology. May2020, Vol. 157 Issue 2, p379-385. 7p.

    مصطلحات موضوعية: *ANTIBODY-drug conjugates, *OVARIAN cancer, *OVARIAN epithelial cancer, *MONOCLONAL antibodies, *FALLOPIAN tubes, *PERITONEAL cancer


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث